Hadassah

Hadassah Hosts Israel Heart Society Conference Highlighting Israel’s Cardiac Innovations

Tuesday, Apr 30 2013

With Prof. Chaim Lotan, head of Hadassah's Heart Institute and Outgoing President of the Israel Heart Society (IHS) as host along with IHS Secretary-General Dr. Amit Segev, over 1,000 cardiologists from around the world participated in the IHS's international conference in Jerusalem, celebrating its 60th anniversary and spotlighting Israel's major contributions to the treatment of cardiovascular disease.

Commemorating three of these cardiac contributions, Israel's Philatelic Service recently issued three new postage stamps. One features a percutaneous (inserted through the skin) artificial heart valve; another highlights stents (metal mesh cylinders that release medication and hold open damaged or collapsed coronary arteries); and a third contains an illustration of an implanted defibrillator that electrically regulates a heartbeat. The stamps were unveiled at the IHS conference by Philatelic Service Director Yaron Razon.

Among the leading foreign guests at the conference were American College of Cardiology President Prof. John Harold and European Society of Cardiology President Prof. Panos Vardas. In an interview with The Jerusalem Post, Prof. Harold, a cardiologist at Cedar-Sinai Medical Center in California, related that he has trained many Israeli cardiologists and described the growth of cardiac services in Israel as "nothing short of extraordinary." He also commented: "Israeli cardiologists have great bench-to-bedside developments. Israel is one of the safest parts of the world to have a heart attack."

Prof. Lotan told the audience that the mortality rate from cardiovascular disease has dropped in recent decades by half, and that 90 percent of acute cardiovascular events are treated immediately with catheterization. In addition, he noted that in the last four years, about 1,500 artificial heart valves have been implanted via catheter to replace faulty ones in patients for whom open-heart surgery is counterindicated.

Read more in The Jerusalem Post>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More